ARCHIVES

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Trials Listed

March 30, 2007

In Brief: Money Bill Delay Seen Until After Election ACCC Meeting Planned On Community Programs

September 15, 1978

Cancer Policy; Cost Containment Impedes Research, Cancer Panel Finds

October 17, 1997

Medicare Cuts Proposed In budget reduction Amendment For FY94

November 19, 1993

Cancer Meetings Listed

April 15, 1994

ASCO, AACR Hold Last Joint annual Meeting, Vow to Encourage Basic-Clinical Interaction

May 28, 1993